Autoimmunity Flashcards
Paul Erlich (1900s) introduced the phenomenon he called “__________” or “_________”
“horror autotoxicus” or “fear of self-poisoning”
The immune system could attack the very host it was intended to protect
“horror autotoxicus” or “fear of self-poisoning”
___________ are targeted toward self-antigens resulting to organ and tissue damage
immune response
Can be caused by T-cell–mediated immune
responses or autoantibodies that are directed
against host antigens
autoimmune diseases
The ability of the immune system to accept
self-antigens and not initiate a response against
them
self tolerance
A state of immune unresponsiveness that is directed against a specific antigen, in this case, a self-antigen
immunologic tolerance
2 levels of immune tolerance
central tolerance
peripheral tolerance
Occurs in the central or primary lymphoid organs,
the thymus, and the bone marrow; Negative and
Positive Selection during T cell maturation; Receptor editing in B cells
central tolerance
Can result from anergy (a specific state of
unresponsiveness to the antigens) caused by the
absence of a costimulatory signal from an
antigen-presenting cell (APC) or binding of inhibitory receptors such as CTLA-4 (a molecule that prevents T-cell activation)
peripheral tolerance
A molecule that prevents T-cell activation
CTLA-4
More prevalent among family members and among monozygotic (genetically identical) twins than dizygotic (non-identical) twins or siblings
genetics
Women are 2.7 times more likely to acquire an
autoimmune disease than men; about 78% of
patients with autoimmune diseases are females; the stimulatory effects of female hormones may place women at a greater risk for developing autoimmune disease
hormonal influence
female hormones affected in autoimmune disease
Estrogen
Androgen
Prolactin
“Immunologic tolerance” some self-antigens may
be cryptic, or hidden within the tissues of the host. T and B lymphocytes are shielded from these
sequestered antigens and are not educated to
become tolerant to them
TISSUE TRAUMA AND RELEASE OF CRYPTIC ANTIGENS
TISSUE TRAUMA AND RELEASE OF CRYPTIC ANTIGENS
Tissue damage could be caused by factors such as:
infections
contact with environmental toxins
physical injury from exposure to ultraviolet (UV) radiation
Bacteria, viruses, and other infectious pathogens
may be able to trigger autoimmune responses
microbial infections
many bacterial or viral agents
contain antigens that closely resemble the structure or amino acid sequence of self-antigens
molecular mimicry
the microorganism can induce a local inflammatory response that recruits leukocytes and stimulates APCs to release cytokines that nonspecifically activate T cells; some of the T cells that are activated may have specificity for self-antigens
bystander effect
proteins that are produced by various microbes that have the ability to bind to both class II MHC molecules and TCRs, regardless of their antigen specificity
superantigens
can cause polyclonal activation of B cells
Epstein-Barr virus (EBV) and cytomegalovirus (CMV)
_______ refers to modifications in gene expression that are not caused by changes in the original DNA sequence.
epigenetics
can induce epigenetic changes by increasing or decreasing methylation of cytosine bases, modifying histones, and causing abnormal regulation by microRNAs; underexpression of certain genes in the immune system may result in
homeostatic imbalances and a breakdown of
self-tolerance, leading to autoimmunity
Triggered by exposure to environmental
toxins, ingestion of harmful foods or drugs,
or the aging process
Exposure to environmental factors can lead
to changes at the protein level; post-translational modifications and may involve biochemical processes such as:
acetylation
lipidation
citrullination
glycosylation
may cause break in immunologic tolerance,
autoreactive T cells recognize and proliferate in
response to self-antigens and B cells develop into
plasma cells that secrete autoantibodies
complex interactions between genetic and environmental factors
Chronic
Peak age of onset: 20-40 years old
W:M – 9:1, 5 yr
Survival rate – 90%
SLE
Complex interactions between environmental
factors, genetic susceptibility, and abnormalities
within the immune system; genetic defects in genes coding for HLA-A1, B8, and DR3
SLE
increases the chance of developing lupus; polymorphisms in genes, genes coding for various cytokines, and genes involved in signaling of innate immune responses - result in uncontrolled autoreactivity of T and B cells, which leads to the production of numerous autoantibodies
HLA-A1
B8
DR3
Antibodies to double-stranded DNA (dsDNA),
histones, and other nuclear components, as well as
autoantibodies to lymphocytes, erythrocytes,
platelet, phospholipids, ribosomal components, and endothelium
SLE
_______ are present in 70% of patients with lupus and are highly specific for the disease
Antibodies to dsDNA
________ and _________ have been found in immune complexes that are deposited in organs such as the kidneys and skin
Anti-dsDNA and complement proteins
_______ are attracted to the sites of inflammation and release cytokines that perpetuate the response, resulting in tissue damage
Leukocytes
Antibodies to RBCs
hemolytic anemia
Antibodies to platelets
thrombocytopenia
inflammation of the blood vessels and vascular
damage in lupus, which may be responsible for
the vasculitis and neuropsychiatric symptoms
Antibodies to endothelial cells
associated with increased miscarriage, stillbirth, and preterm delivery in pregnant women with lupus
Phospholipid antibodies
occurs in up to 8% of babies born to pregnant women with SLE, is associated with antibodies to the nuclear antigens, SS-A/Ro and SS-B/La
neonatal lupus
neonatal lupus antigens
SS-A/Ro
SS-B/La
SLE
fatigue, weight loss, malaise, fever, and anorexia are often the first to appear
Nonspecific symptoms
SLE
______ and ______ in 90% of patients
(arthritis is symmetric and involves the small joints of the hands, wrists, and knees)
Polyarthralgias or arthritis
________ may appear on any area of the
body exposed to UV light in 80% of patients
(butterfly rash across the nose and cheeks)
Erythematous rash
drug-induced lupus
procainamide, hydralazine, chlorpromazine, isoniazid, quinidine, anticonvulsants such as methyldopa, and possibly oral contraceptives
Acute cutaneous lupus, chronic cutaneous lupus,
oral ulcers, non-scarring alopecia (thinning or
fragility of the hair), synovitis, serositis, renal
involvement, neurological symptoms, hemolytic
anemia, leukopenia, and thrombocytopenia
clinical criteria
Elevated antinuclear antibody titer, elevated
anti-dsDNA titer, presence of antibody to the Sm
nuclear antigen, presence of antiphospholipid
antibody, low complement levels, and positive direct Coombs’ test in the absence of hemolytic anemia
immunologic criteria
A patient must satisfy at least __ of the 17 criteria,
including at least one clinical criterion and one
immunologic criterion, to be classified as having
SLE
4
SLE
For mild symptoms, a high dose of _______ or
other anti-inflammatory drug may bring relief
aspirin
SLE
For skin manifestations, antimalarials such as
__________ or ________ and _________ are often prescribed
hydroxychloroquine
chloroquine
topical steroids
The antimalarial drugs are thought to inhibit
signaling of _____, __, and __
TLR 7, 8, and 9
used for acute fulminant (severe and sudden) lupus, lupus nephritis, or central nervous system (CNS) complications because these suppress the immune response and lower antibody titers
Systemic corticosteroids
laboratory diagnosis of SLE
Complete blood count (CBC), platelet count, and
urinalysis, quantification of complement
proteins (C3) and the detection of specific
autoantibodies
Autoantibodies that are directed against antigens in the nuclei of mammalian cells
ANTI-NUCLEAR ANTIBODIES (ANAs)
Produce a peripheral or a homogeneous staining
pattern on indirect immunofluorescence (IIF)
DOUBLE-STRANDED DNA (dsDNA) ANTIBODIES
ANTIHISTONE ANTIBODIES
_______ are nucleoproteins that are essential components of chromatin
histones
ANTIHISTONE ANTIBODIES
five major classes of histones:
H1, H2A, H2B, H3, and H4
ANTIHISTONE ANTIBODIES:
Antibodies to ____ and ___ can be detected in
almost all patients with drug-induced lupus
H2A and H2B
Also found in RA, Felty’s syndrome, Sjögren’s
syndrome, systemic sclerosis, and primary biliary
cirrhosis, but the levels are usually lower
antihistone antibodies
antihistone antibodies pattern in IIF assay
homogeneous pattern
Stimulated by DNA-histone complexes;
nucleosomes, or deoxyribonucleoprotein (DNP)
nucleosome antibodies
Directed only against the complexes and not against DNA or the individual histones
nucleosome antibodies
Found in about 85% of patients with SLE and their
levels correlate with disease severity
nucleosome antibodies
nucleosome antibodies pattern in IIF assay
homogeneous
associated with uridine-rich RNA
extractable nuclear antigens (ENA)
Found in only 20% to 40% of patients with SLE,
depending on the race of the population
antibody to Sm antigen
anti-Sm antibody pattern in IIF
coarse speckled pattern of nuclear fluorescence
anti-RNP antibody pattern in IIF
coarse speckled pattern
anti-RNP antibody meaning
anti-ribonucleoproteins antibody
Detected in 20% to 30% of patients with SLE, but
are also found at a high titer in individuals with
mixed connective tissue disease and in lower levels
in patients with other autoimmune rheumatic
diseases such as systemic sclerosis, Sjögren’s
syndrome, and RA
anti-RNP antibody
Appears in approximately 24% to 60% of patients
with SLE and has been closely associated with the
presence of nephritis, vasculitis,
lymphadenopathy, photosensitivity, and
hematologic manifestations such as leukopenia
ANTI-SS-A/Ro
Found in only 9% to 35% of patients with SLE and
all of these have anti–SS-A/Ro; most often found in
patients who have cutaneous manifestations of
SLE, especially photosensitivity dermatitis
ANTIBODIES TO SS-B/La
Can cross the placenta and have been associated
with neonatal lupus
ANTIBODIES TO BOTH SS-A/Ro and SS-B/La
a prominent structure within the
nucleus where transcription and processing of
ribosomal RNA and assembly of the ribosomes
takes place
nucleolus
Common in systemic sclerosis (also known as
scleroderma)
ANTIBODY TO FIBRILLARIN
ANTIBODY TO FIBRILLARIN pattern in IIF
clumpy nucleolar fluorescence
Associated with scleroderma
ANTIBODIES TO RNA POLYMERASE
ANTIBODIES TO RNA POLYMERASE pattern in IIF
speckled nucleolar pattern
Also known as PM/Scl
ANTIBODIES TO PM-1 ANTIGEN
Found in polymyositis and systemic sclerosis;
homogeneous staining of the nucleolus
ANTIBODIES TO PM-1 ANTIGEN
Bind to proteins in the middle region of a
chromosome where the sister chromatids are joined; directed against three centromere antigens of molecular weights 16kDa, 80kDa, and 120kDa
ANTICENTROMERE ANTIBODIES
3 centromere antigens molecular weights:
16kDa
80kDa
120kDa
Found in 50% to 80% of patients with the CREST
syndrome
ANTICENTROMERE ANTIBODIES
CREST syndrome:
Calcinosis, Raynaud’s
phenomenon, Esophageal dysmotility,
Sclerodactyly, Telangiectasia
anticentromere antibodies pattern
discrete speckled staining in the nuclei
of the cells
methods of ANA detection
IIF, immunoperoxidase staining,
enzyme-linked immunosorbent assay (ELISA),
microsphere multiplex immunoassays (MIA),
radioimmunoassay (RIA), immunodiffusion,
immunoblotting (Western blot), dot blot,
immunoelectrophoresis, and microarray
Heterogeneous group of antibodies that bind to
phospholipids alone or phospholipids complexed
with protein
ANTIPHOSPHOLIPID ANTIBODIES
Associated with deep-vein and arterial thrombosis
and with recurrent pregnancy loss
antiphospholipid antibodies